International Phyllodes Tumor Webinar 2026
Phyllodes tumors are rare breast tumors that can present unique challenges for patients, caregivers, healthcare professionals, and researchers. Because of their rarity, access to reliable information and expert guidance is often limited.
Join leading international experts as they share the latest insights into the diagnosis, pathology, treatment, follow-up care, and current research on phyllodes tumors. The webinar will also highlight the importance of patient advocacy and international collaboration in advancing knowledge and improving care worldwide.
This webinar will be conducted entirely in English.
Speakers
• Dr. Frederieke van Duijnhoven (The Netherlands)
Surgical Oncologist, Netherlands Cancer Institute (Antoni van Leeuwenhoek), Amsterdam.
• Dr. Laura Rosenberger (United States)
Duke University, Phyllodes Tumor Specialist.
• Dr. Mahbubl Ahmed (United Kingdom)
Clinical Oncologist, Proton International London. Specialist in soft tissue and bone sarcomas.
• Marloes van Esterik-Zwemmer (The Netherlands)
Host and Speaker, Dutch Phyllodes Group.
Topics (Subject to Confirmation)
The final program is currently being developed. Topics may include:
• Diagnosis and pathology of phyllodes tumors
• Surgical treatment and clinical management
• Follow-up care and recurrence
• Current and future research initiatives
• Patient advocacy
• International collaboration
• Live Q&A with the expert panel
Participants are encouraged to submit questions during registration. A selection of questions will be addressed during the webinar.
📅 Date: November 27, 2026
🕔 Time: 5:00 PM CET (Netherlands) | 11:00 AM EST (United States)
💻 Location: Online via Microsoft Teams
Hosted by the Dutch Phyllodes Group, part of the Dutch Sarcoma Patient Platform (PPS), in collaboration with Frederieke van Duijnhoven of the Netherlands Cancer Institute (Antoni van Leeuwenhoek), Amsterdam.
🌐 www.phyllodes.nl
🌐 www.phyllodestumor.org
Only together we can increase awareness of phyllodes tumors, advance research, share knowledge, and improve care for everyone affected by this rare disease.